1,196
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Analyses of the toxic properties of recombinant human Cyclophilin A in mice

, , , , , & show all
Pages 182-190 | Received 28 Feb 2019, Accepted 04 Sep 2019, Published online: 24 Oct 2019
 

Abstract

Cyclophilin A (CypA), an 18 kDa multi-functional protein with cistrans isomerase activity, is both a ligand for cyclosporine A and a proinflammatory factor. CypA is also a chemoattractant for hemopoietic stem cells and progenitors of different lineages, and can mediate regenerative processes in an organism. Accumulated experimental data have suggested there are practical applications for this protein in the treatment of several diseases (i.e. neutralization of cyclosporine A side effects, etc.). However, the range of CypA safe doses as well as its toxic effects remain unknown. The study here investigated the acute toxicity of a single intraperitoneal (IP) or subcutaneous (SC) dosing of recombinant human CypA (rhCypA) in both female and male mice and its effect on gene expression of acute phase proteins (APP) in the female mice after IP treatment. The results showed that toxicity of rhCypA was most evident in female and male mice dosed IP with 750 mg/kg, and manifested as kidney injury and increased granulocyte/lymphocyte ratios in the blood. Enhanced expression of Sаа1 and Sаа2 genes was induced with doses of 0.1–2 mg/mouse of rhCypA. Injection of the maximal dose (750 mg/kg) significantly stimulated expression of all the APP genes studied.

Disclosure statement

The authors declare no conflict of interest, financial or otherwise. The authors alone are responsible for the content of this manuscript.

Additional information

Funding

This study was supported by the Ministry of Industry and Trade of the Russian Federation (Grant#12411.1008799.13.004) and by the Russian Foundation for Basic Research (Grant #16–04-00933).